Compare, Analyse Sun Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    SUN PHARMA
Mar-21
TEVA PHARMA
Dec-13
SUN PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6543,123-   
Low Rs3392,713-   
Sales per share (Unadj.) Rs139.61,792.6-  
Earnings per share (Unadj.) Rs9.5112.0-  
Cash flow per share (Unadj.) Rs18.2256.9-  
Dividends per share (Unadj.) Rs7.5098.03-  
Avg Dividend yield %1.53.4 45.0%  
Book value per share (Unadj.) Rs193.61,991.2-  
Shares outstanding (eoy) m2,399.34848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.61.6 218.3%   
Avg P/E ratio x52.126.1 199.9%  
P/CF ratio (eoy) x27.311.4 240.1%  
Price / Book Value ratio x2.61.5 174.8%  
Dividend payout %78.887.5 90.0%   
Avg Mkt Cap Rs m1,190,4302,474,778 48.1%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m68,6220-   
Avg. sales/employee Rs ThNM33,821.3-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,112.8-  
INCOME DATA
Net Sales Rs m334,9811,520,097 22.0%  
Other income Rs m8,5920-   
Total revenues Rs m343,5731,520,097 22.6%   
Gross profit Rs m41,616416,279 10.0%  
Depreciation Rs m20,800122,871 16.9%   
Interest Rs m1,41429,857 4.7%   
Profit before tax Rs m27,994263,551 10.6%   
Minority Interest Rs m01,197 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-173,007 0.0%   
Tax Rs m5,147-3,218 -160.0%   
Profit after tax Rs m22,84794,959 24.1%  
Gross profit margin %12.427.4 45.4%  
Effective tax rate %18.4-1.2 -1,505.9%   
Net profit margin %6.86.2 109.2%  
BALANCE SHEET DATA
Current assets Rs m304,4211,026,668 29.7%   
Current liabilities Rs m161,456895,341 18.0%   
Net working cap to sales %42.78.6 494.0%  
Current ratio x1.91.1 164.4%  
Inventory Days Days14991 164.2%  
Debtors Days Days9996 102.9%  
Net fixed assets Rs m336,682496,497 67.8%   
Share capital Rs m2,3993,742 64.1%   
"Free" reserves Rs m462,2290-   
Net worth Rs m464,6281,688,539 27.5%   
Long term debt Rs m8,981777,259 1.2%   
Total assets Rs m641,1033,473,908 18.5%  
Interest coverage x20.89.8 211.6%   
Debt to equity ratio x00.5 4.2%  
Sales to assets ratio x0.50.4 119.4%   
Return on assets %3.83.6 105.3%  
Return on equity %4.95.6 87.4%  
Return on capital %6.24.9 125.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m54,1590-   
CASH FLOW
From Operations Rs m61,704242,225 25.5%  
From Investments Rs m5,362-85,830 -6.2%  
From Financial Activity Rs m-59,805-290,565 20.6%  
Net Cashflow Rs m5,964-134,170 -4.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.83 Rs / USD

Compare SUN PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare SUN PHARMA With: RAYMED LABS  MEDICAMEN BI  HIKAL.  ORTIN LABS   IND SWIFT LA  



Today's Market

Sensex Falls Over 500 Points, Dow Futures Down by 105 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 555 points, down 0.9%, at 60,704 levels.

Related Views On News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Sun Pharma's Stock Falls 4% After Its March Quarter Results (Views On News)

May 28, 2021

In the past three months, the stock has outperformed the market by gaining nearly 20%. Can it go higher?

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Modi's Big Move Could Boost these 5 Defence Stocks (Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution (Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUN PHARMA SHARE PRICE


Oct 21, 2021 02:52 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - CONCORD DRUGS COMPARISON

COMPARE SUN PHARMA WITH

FEATURED VIDEOS

Why a Simple Portfolio Beat Quality Bluechips by 2x

How to Pick Multibagger Stocks

IRCTC: Buy, Hold or Sell

What to Look for in an IPO

More Featured Videos

MARKET STATS